SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending after delivering a significant earnings beat and providing optimistic revenue guidance driven by strong data center and AI infrastructure demand. Community sentiment is electric, with investors celebrating a massive rally while debating whether this momentum marks the start of a long-term growth phase or if the stock is reaching unsustainable bubble territory.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently a focal point for investors as the community debates its aggressive diversification into the beverage sector and recent corporate actions. The stock is generating significant discussion regarding potential short-squeeze activity and skepticism over management's long-term strategy, with sentiment split between those awaiting federal legalization catalysts and those frustrated by continued dilution and share price performance.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing significant selling pressure and volatility as investors rotate capital into other semiconductor names like AMD and Micron, leading to a period of consolidation despite robust long-term demand for AI infrastructure. The community is actively debating the stock's stagnant performance, with many concerned about market manipulation and whether recent competitive announcements will impact Nvidia's dominant market position.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio Inc. is trending as the community rallies around the stock's potential for global expansion and the continued anticipation of clinical data updates while highlighting the high level of short interest. Investors are closely monitoring the leadership's communications and trial progress, with the community actively debating the company's regulatory challenges and upcoming earnings catalyst.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as aggressive call-buying and massive demand for AI infrastructure trigger a parabolic rally, with investors actively debating whether the company is successfully breaking out of its historical cyclicality. Community sentiment is deeply polarized between bullish participants targeting significantly higher price levels due to supply constraints and bears warning that the rapid valuation expansion resembles past speculative bubbles.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending after an earnings report that emphasized significant margin expansion and robust AI demand, helping to restore investor confidence despite a revenue miss. The community is actively discussing the stock's potential for a short squeeze, the resolution of negative sentiment surrounding legal investigations, and the long-term re-rating of the company based on its AI data center infrastructure growth.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF ($DRAM) is surging as investors look for a pure-play vehicle to capture the memory supercycle, specifically the massive demand for HBM and NAND storage in AI infrastructure. The community is highly bullish, viewing this ETF as an essential way to gain exposure to the "Big Three" memory leadersSamsung, SK Hynix, and Micronwhich are currently seen as the critical bottleneck in the AI economy.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart shares are facing intense selling pressure following a quarterly earnings report where profit metrics disappointed investors despite revenue surpassing expectations. The community is heavily divided, with some expressing deep frustration over the lack of consistent profitability and the stock's long-term performance, while others view the current price action as an overreaction and look for potential signs of a short squeeze.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is attracting significant attention as users highlight its expanding real-world utility, including decentralized cloud sovereignty and AI integration through the Caffeine AI platform. While bulls point to growing network activity and developer engagement as catalysts for long-term value, the community remains divided, with skeptics frequently debating concerns over tokenomics and historical price performance.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting intense community debate as investors react to the company's Q1 performance, ongoing dilution concerns, and upcoming shareholder votes on reverse splits. While some are closely monitoring the commercial rollout of its fibromyalgia treatment and looking for validation from institutional holdings, others express frustration over share price suppression and management's capital-raising strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, presented...

Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced it will host its first quarter 2026 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 7, 2026...

Ironwood Pharmaceuticals (IRWD) Projected to Post Earnings on Wednesday

Ironwood Pharmaceuticals (NASDAQ:IRWD) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-ironwood-pharmaceuticals-inc-stock...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 7.3% - Here's What Happened

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 7.3% Higher - What's Next...

Zacks Research Has Bearish Estimate for IRWD Q2 Earnings

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Analysts at Zacks Research cut their Q2 2026 earnings per share estimates for Ironwood Pharmaceuticals in a research note issued on...

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week 2026

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced...

Zacks Research Issues Positive Outlook for IRWD Earnings

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities researchers at Zacks Research upped their Q4 2026 earnings per share estimates for Ironwood Pharmaceuticals in a note issued to...

Ironwood Pharmaceuticals (NASDAQ:IRWD)  Shares Down 6%   - Here's What Happened

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 6% - Here's Why...

Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last?

Nektar (NKTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Update

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 17,904,692 shares, an increase of 30.7% from the March 15th total of 13,703,587 shares. Based on an...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest IRWD News

IRWDIronwood Pharmaceuticals Inc - Ordinary Shares - Class A